SpyGlass Pharma (SGP)
Develops sustained drug delivery for chronic eye conditions within established surgical workflows.
$28.35
At close+1.49 (+5.55%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$0.66
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
————Mar '26May '26Aug '26Nov '26
Reported————−$5.72−$0.69−$0.59Pending
Estimate————−$0.57−$0.50−$0.51−$0.66
Surprise————−896.1%−37.1%−14.7%—
RevenueReportedEstimate
————Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.66 | — | — |
| Aug 2026 | −$0.51 | −$0.59 | −14.7% |
| Jun 2026 | −$0.67 | — | — |
| Jun 2026 | −$0.50 | — | — |
| May 2026 | −$0.50 | −$0.69 | −37.1% |
| Mar 2026 | −$0.57 | −$5.72 | −896.1% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.66 | — | — | — | — | — | — |
| Aug 6, 2026 | −$0.51 | −$0.59 | −14.7% | — | — | — | +2.3% |
| Jun 25, 2026 | −$0.67 | — | — | — | — | — | — |
| Jun 8, 2026 | −$0.50 | — | — | — | — | — | — |
| May 14, 2026 | −$0.50 | −$0.69 | −37.1% | — | — | — | −4.4% |
| Mar 26, 2026 | −$0.57 | −$5.72 | −896.1% | — | — | — | −10.3% |